CLL.L Regulatory News (CLL)

Cello Group plc (the "Group" or the "Company")

Additional listing / TVR

The Company announces that on 7 May 2014 it resolved to issue 123,588 new ordinary shares of 10p each to vendors of a business previously acquired by the Group. These shares are to be issued pursuant to the share purchase agreement in relation to Mash Healthcare Group Limited

Application has been made for these shares to be admitted to trading on AIM and admission is expected to occur on 13 May 2014. The Company's issued share capital, following the admission of the 123,588 new shares, will be 83,897,661 ordinary shares of 10 pence each ("Ordinary Shares"), all with voting rights. The Company holds 453,000 Ordinary Shares in treasury at the date of this announcement. The total number of current voting rights in the Company will therefore be 83,444,661 shares.

The above figure (83,444,661 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

8 May 2014

For further Information please contact:

Cello Group plc 020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Group Finance Director

Cenkos Securities plc 020 7397 8900

Bobbie Hilliam

Harry Pardoe